 | • レポートコード：MRC308GR11535 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のピラジナミド錠の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のピラジナミド錠市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ピラジナミド錠の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ピラジナミド錠市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・0.5g/粒、0.25g/粒
用途別セグメント
・病院、診療所、ドラッグストア
主要な市場プレーヤー
・Akorn Operating、Healthy Life Pharma、Wellona Pharma、Lupin、Akorn、Cadila Pharmaceuticals、Macleods Pharma、Morningside Healthcare、Datong Liqun Pharmaceutical、Guangdong Taicheng Pharmaceutical、Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical)、Changchun Maoshun Pharmaceutical、Jiangsu Sihuan Bioengineering Pharmaceutical、Chongqing Huapont Pharmaceutical、Suzhou Homesun Pharmaceutical、Chengdu Jinhua Pharmaceutical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ピラジナミド錠製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なピラジナミド錠メーカーの企業概要、2019年～2022年までのピラジナミド錠の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なピラジナミド錠メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ピラジナミド錠の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのピラジナミド錠の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのピラジナミド錠市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびピラジナミド錠の産業チェーンを掲載しています。
・第14、15章では、ピラジナミド錠の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ピラジナミド錠の概要
– 種類別分析（2018年vs2022年vs2029年）：0.5g/粒、0.25g/粒
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所、ドラッグストア
– 世界のピラジナミド錠市場規模・予測
– 世界のピラジナミド錠生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Akorn Operating、Healthy Life Pharma、Wellona Pharma、Lupin、Akorn、Cadila Pharmaceuticals、Macleods Pharma、Morningside Healthcare、Datong Liqun Pharmaceutical、Guangdong Taicheng Pharmaceutical、Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical)、Changchun Maoshun Pharmaceutical、Jiangsu Sihuan Bioengineering Pharmaceutical、Chongqing Huapont Pharmaceutical、Suzhou Homesun Pharmaceutical、Chengdu Jinhua Pharmaceutical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：0.5g/粒、0.25g/粒
・用途別分析2018年-2029年：病院、診療所、ドラッグストア
・ピラジナミド錠の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ピラジナミド錠のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ピラジナミド錠のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ピラジナミド錠の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ピラジナミド錠の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Pyrazinamide Tablets
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pyrazinamide Tablets Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 0.5g/Tablet
1.3.3 0.25g/Tablet
1.4 Market Analysis by Application
1.4.1 Overview: Global Pyrazinamide Tablets Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Drugstore
1.5 Global Pyrazinamide Tablets Market Size & Forecast
1.5.1 Global Pyrazinamide Tablets Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Pyrazinamide Tablets Sales Quantity (2018-2029)
1.5.3 Global Pyrazinamide Tablets Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Akorn Operating
2.1.1 Akorn Operating Details
2.1.2 Akorn Operating Major Business
2.1.3 Akorn Operating Pyrazinamide Tablets Product and Services
2.1.4 Akorn Operating Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Akorn Operating Recent Developments/Updates
2.2 Healthy Life Pharma
2.2.1 Healthy Life Pharma Details
2.2.2 Healthy Life Pharma Major Business
2.2.3 Healthy Life Pharma Pyrazinamide Tablets Product and Services
2.2.4 Healthy Life Pharma Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Healthy Life Pharma Recent Developments/Updates
2.3 Wellona Pharma
2.3.1 Wellona Pharma Details
2.3.2 Wellona Pharma Major Business
2.3.3 Wellona Pharma Pyrazinamide Tablets Product and Services
2.3.4 Wellona Pharma Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Wellona Pharma Recent Developments/Updates
2.4 Lupin
2.4.1 Lupin Details
2.4.2 Lupin Major Business
2.4.3 Lupin Pyrazinamide Tablets Product and Services
2.4.4 Lupin Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lupin Recent Developments/Updates
2.5 Akorn
2.5.1 Akorn Details
2.5.2 Akorn Major Business
2.5.3 Akorn Pyrazinamide Tablets Product and Services
2.5.4 Akorn Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Akorn Recent Developments/Updates
2.6 Cadila Pharmaceuticals
2.6.1 Cadila Pharmaceuticals Details
2.6.2 Cadila Pharmaceuticals Major Business
2.6.3 Cadila Pharmaceuticals Pyrazinamide Tablets Product and Services
2.6.4 Cadila Pharmaceuticals Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cadila Pharmaceuticals Recent Developments/Updates
2.7 Macleods Pharma
2.7.1 Macleods Pharma Details
2.7.2 Macleods Pharma Major Business
2.7.3 Macleods Pharma Pyrazinamide Tablets Product and Services
2.7.4 Macleods Pharma Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Macleods Pharma Recent Developments/Updates
2.8 Morningside Healthcare
2.8.1 Morningside Healthcare Details
2.8.2 Morningside Healthcare Major Business
2.8.3 Morningside Healthcare Pyrazinamide Tablets Product and Services
2.8.4 Morningside Healthcare Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Morningside Healthcare Recent Developments/Updates
2.9 Datong Liqun Pharmaceutical
2.9.1 Datong Liqun Pharmaceutical Details
2.9.2 Datong Liqun Pharmaceutical Major Business
2.9.3 Datong Liqun Pharmaceutical Pyrazinamide Tablets Product and Services
2.9.4 Datong Liqun Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Datong Liqun Pharmaceutical Recent Developments/Updates
2.10 Guangdong Taicheng Pharmaceutical
2.10.1 Guangdong Taicheng Pharmaceutical Details
2.10.2 Guangdong Taicheng Pharmaceutical Major Business
2.10.3 Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Product and Services
2.10.4 Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Guangdong Taicheng Pharmaceutical Recent Developments/Updates
2.11 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical)
2.11.1 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Details
2.11.2 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Major Business
2.11.3 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Product and Services
2.11.4 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Recent Developments/Updates
2.12 Changchun Maoshun Pharmaceutical
2.12.1 Changchun Maoshun Pharmaceutical Details
2.12.2 Changchun Maoshun Pharmaceutical Major Business
2.12.3 Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Product and Services
2.12.4 Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Changchun Maoshun Pharmaceutical Recent Developments/Updates
2.13 Jiangsu Sihuan Bioengineering Pharmaceutical
2.13.1 Jiangsu Sihuan Bioengineering Pharmaceutical Details
2.13.2 Jiangsu Sihuan Bioengineering Pharmaceutical Major Business
2.13.3 Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Product and Services
2.13.4 Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jiangsu Sihuan Bioengineering Pharmaceutical Recent Developments/Updates
2.14 Chongqing Huapont Pharmaceutical
2.14.1 Chongqing Huapont Pharmaceutical Details
2.14.2 Chongqing Huapont Pharmaceutical Major Business
2.14.3 Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Product and Services
2.14.4 Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
2.15 Suzhou Homesun Pharmaceutical
2.15.1 Suzhou Homesun Pharmaceutical Details
2.15.2 Suzhou Homesun Pharmaceutical Major Business
2.15.3 Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Product and Services
2.15.4 Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
2.16 Chengdu Jinhua Pharmaceutical
2.16.1 Chengdu Jinhua Pharmaceutical Details
2.16.2 Chengdu Jinhua Pharmaceutical Major Business
2.16.3 Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Product and Services
2.16.4 Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Chengdu Jinhua Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Pyrazinamide Tablets by Manufacturer
3.1 Global Pyrazinamide Tablets Sales Quantity by Manufacturer (2018-2023)
3.2 Global Pyrazinamide Tablets Revenue by Manufacturer (2018-2023)
3.3 Global Pyrazinamide Tablets Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Pyrazinamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Pyrazinamide Tablets Manufacturer Market Share in 2022
3.4.2 Top 6 Pyrazinamide Tablets Manufacturer Market Share in 2022
3.5 Pyrazinamide Tablets Market: Overall Company Footprint Analysis
3.5.1 Pyrazinamide Tablets Market: Region Footprint
3.5.2 Pyrazinamide Tablets Market: Company Product Type Footprint
3.5.3 Pyrazinamide Tablets Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Pyrazinamide Tablets Market Size by Region
4.1.1 Global Pyrazinamide Tablets Sales Quantity by Region (2018-2029)
4.1.2 Global Pyrazinamide Tablets Consumption Value by Region (2018-2029)
4.1.3 Global Pyrazinamide Tablets Average Price by Region (2018-2029)
4.2 North America Pyrazinamide Tablets Consumption Value (2018-2029)
4.3 Europe Pyrazinamide Tablets Consumption Value (2018-2029)
4.4 Asia-Pacific Pyrazinamide Tablets Consumption Value (2018-2029)
4.5 South America Pyrazinamide Tablets Consumption Value (2018-2029)
4.6 Middle East and Africa Pyrazinamide Tablets Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Pyrazinamide Tablets Sales Quantity by Type (2018-2029)
5.2 Global Pyrazinamide Tablets Consumption Value by Type (2018-2029)
5.3 Global Pyrazinamide Tablets Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Pyrazinamide Tablets Sales Quantity by Application (2018-2029)
6.2 Global Pyrazinamide Tablets Consumption Value by Application (2018-2029)
6.3 Global Pyrazinamide Tablets Average Price by Application (2018-2029)
7 North America
7.1 North America Pyrazinamide Tablets Sales Quantity by Type (2018-2029)
7.2 North America Pyrazinamide Tablets Sales Quantity by Application (2018-2029)
7.3 North America Pyrazinamide Tablets Market Size by Country
7.3.1 North America Pyrazinamide Tablets Sales Quantity by Country (2018-2029)
7.3.2 North America Pyrazinamide Tablets Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Pyrazinamide Tablets Sales Quantity by Type (2018-2029)
8.2 Europe Pyrazinamide Tablets Sales Quantity by Application (2018-2029)
8.3 Europe Pyrazinamide Tablets Market Size by Country
8.3.1 Europe Pyrazinamide Tablets Sales Quantity by Country (2018-2029)
8.3.2 Europe Pyrazinamide Tablets Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Pyrazinamide Tablets Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Pyrazinamide Tablets Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Pyrazinamide Tablets Market Size by Region
9.3.1 Asia-Pacific Pyrazinamide Tablets Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Pyrazinamide Tablets Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Pyrazinamide Tablets Sales Quantity by Type (2018-2029)
10.2 South America Pyrazinamide Tablets Sales Quantity by Application (2018-2029)
10.3 South America Pyrazinamide Tablets Market Size by Country
10.3.1 South America Pyrazinamide Tablets Sales Quantity by Country (2018-2029)
10.3.2 South America Pyrazinamide Tablets Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Pyrazinamide Tablets Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Pyrazinamide Tablets Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Pyrazinamide Tablets Market Size by Country
11.3.1 Middle East & Africa Pyrazinamide Tablets Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Pyrazinamide Tablets Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Pyrazinamide Tablets Market Drivers
12.2 Pyrazinamide Tablets Market Restraints
12.3 Pyrazinamide Tablets Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Pyrazinamide Tablets and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pyrazinamide Tablets
13.3 Pyrazinamide Tablets Production Process
13.4 Pyrazinamide Tablets Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pyrazinamide Tablets Typical Distributors
14.3 Pyrazinamide Tablets Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Pyrazinamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pyrazinamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Akorn Operating Basic Information, Manufacturing Base and Competitors
Table 4. Akorn Operating Major Business
Table 5. Akorn Operating Pyrazinamide Tablets Product and Services
Table 6. Akorn Operating Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Akorn Operating Recent Developments/Updates
Table 8. Healthy Life Pharma Basic Information, Manufacturing Base and Competitors
Table 9. Healthy Life Pharma Major Business
Table 10. Healthy Life Pharma Pyrazinamide Tablets Product and Services
Table 11. Healthy Life Pharma Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Healthy Life Pharma Recent Developments/Updates
Table 13. Wellona Pharma Basic Information, Manufacturing Base and Competitors
Table 14. Wellona Pharma Major Business
Table 15. Wellona Pharma Pyrazinamide Tablets Product and Services
Table 16. Wellona Pharma Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Wellona Pharma Recent Developments/Updates
Table 18. Lupin Basic Information, Manufacturing Base and Competitors
Table 19. Lupin Major Business
Table 20. Lupin Pyrazinamide Tablets Product and Services
Table 21. Lupin Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Lupin Recent Developments/Updates
Table 23. Akorn Basic Information, Manufacturing Base and Competitors
Table 24. Akorn Major Business
Table 25. Akorn Pyrazinamide Tablets Product and Services
Table 26. Akorn Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Akorn Recent Developments/Updates
Table 28. Cadila Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Cadila Pharmaceuticals Major Business
Table 30. Cadila Pharmaceuticals Pyrazinamide Tablets Product and Services
Table 31. Cadila Pharmaceuticals Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cadila Pharmaceuticals Recent Developments/Updates
Table 33. Macleods Pharma Basic Information, Manufacturing Base and Competitors
Table 34. Macleods Pharma Major Business
Table 35. Macleods Pharma Pyrazinamide Tablets Product and Services
Table 36. Macleods Pharma Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Macleods Pharma Recent Developments/Updates
Table 38. Morningside Healthcare Basic Information, Manufacturing Base and Competitors
Table 39. Morningside Healthcare Major Business
Table 40. Morningside Healthcare Pyrazinamide Tablets Product and Services
Table 41. Morningside Healthcare Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Morningside Healthcare Recent Developments/Updates
Table 43. Datong Liqun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Datong Liqun Pharmaceutical Major Business
Table 45. Datong Liqun Pharmaceutical Pyrazinamide Tablets Product and Services
Table 46. Datong Liqun Pharmaceutical Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Datong Liqun Pharmaceutical Recent Developments/Updates
Table 48. Guangdong Taicheng Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 49. Guangdong Taicheng Pharmaceutical Major Business
Table 50. Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Product and Services
Table 51. Guangdong Taicheng Pharmaceutical Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Guangdong Taicheng Pharmaceutical Recent Developments/Updates
Table 53. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Basic Information, Manufacturing Base and Competitors
Table 54. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Major Business
Table 55. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Product and Services
Table 56. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shenyang Red Flag Pharmaceutical(Fosun Pharmaceutical) Recent Developments/Updates
Table 58. Changchun Maoshun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 59. Changchun Maoshun Pharmaceutical Major Business
Table 60. Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Product and Services
Table 61. Changchun Maoshun Pharmaceutical Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Changchun Maoshun Pharmaceutical Recent Developments/Updates
Table 63. Jiangsu Sihuan Bioengineering Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Jiangsu Sihuan Bioengineering Pharmaceutical Major Business
Table 65. Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Product and Services
Table 66. Jiangsu Sihuan Bioengineering Pharmaceutical Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Jiangsu Sihuan Bioengineering Pharmaceutical Recent Developments/Updates
Table 68. Chongqing Huapont Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Chongqing Huapont Pharmaceutical Major Business
Table 70. Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Product and Services
Table 71. Chongqing Huapont Pharmaceutical Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Chongqing Huapont Pharmaceutical Recent Developments/Updates
Table 73. Suzhou Homesun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Suzhou Homesun Pharmaceutical Major Business
Table 75. Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Product and Services
Table 76. Suzhou Homesun Pharmaceutical Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Suzhou Homesun Pharmaceutical Recent Developments/Updates
Table 78. Chengdu Jinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Chengdu Jinhua Pharmaceutical Major Business
Table 80. Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Product and Services
Table 81. Chengdu Jinhua Pharmaceutical Pyrazinamide Tablets Sales Quantity (K Boxes), Average Price (US$/Box), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Chengdu Jinhua Pharmaceutical Recent Developments/Updates
Table 83. Global Pyrazinamide Tablets Sales Quantity by Manufacturer (2018-2023) & (K Boxes)
Table 84. Global Pyrazinamide Tablets Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Pyrazinamide Tablets Average Price by Manufacturer (2018-2023) & (US$/Box)
Table 86. Market Position of Manufacturers in Pyrazinamide Tablets, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Pyrazinamide Tablets Production Site of Key Manufacturer
Table 88. Pyrazinamide Tablets Market: Company Product Type Footprint
Table 89. Pyrazinamide Tablets Market: Company Product Application Footprint
Table 90. Pyrazinamide Tablets New Market Entrants and Barriers to Market Entry
Table 91. Pyrazinamide Tablets Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Pyrazinamide Tablets Sales Quantity by Region (2018-2023) & (K Boxes)
Table 93. Global Pyrazinamide Tablets Sales Quantity by Region (2024-2029) & (K Boxes)
Table 94. Global Pyrazinamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Pyrazinamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Pyrazinamide Tablets Average Price by Region (2018-2023) & (US$/Box)
Table 97. Global Pyrazinamide Tablets Average Price by Region (2024-2029) & (US$/Box)
Table 98. Global Pyrazinamide Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 99. Global Pyrazinamide Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 100. Global Pyrazinamide Tablets Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Pyrazinamide Tablets Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Pyrazinamide Tablets Average Price by Type (2018-2023) & (US$/Box)
Table 103. Global Pyrazinamide Tablets Average Price by Type (2024-2029) & (US$/Box)
Table 104. Global Pyrazinamide Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 105. Global Pyrazinamide Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 106. Global Pyrazinamide Tablets Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Pyrazinamide Tablets Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Pyrazinamide Tablets Average Price by Application (2018-2023) & (US$/Box)
Table 109. Global Pyrazinamide Tablets Average Price by Application (2024-2029) & (US$/Box)
Table 110. North America Pyrazinamide Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 111. North America Pyrazinamide Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 112. North America Pyrazinamide Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 113. North America Pyrazinamide Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 114. North America Pyrazinamide Tablets Sales Quantity by Country (2018-2023) & (K Boxes)
Table 115. North America Pyrazinamide Tablets Sales Quantity by Country (2024-2029) & (K Boxes)
Table 116. North America Pyrazinamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Pyrazinamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Pyrazinamide Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 119. Europe Pyrazinamide Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 120. Europe Pyrazinamide Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 121. Europe Pyrazinamide Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 122. Europe Pyrazinamide Tablets Sales Quantity by Country (2018-2023) & (K Boxes)
Table 123. Europe Pyrazinamide Tablets Sales Quantity by Country (2024-2029) & (K Boxes)
Table 124. Europe Pyrazinamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Pyrazinamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Pyrazinamide Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 127. Asia-Pacific Pyrazinamide Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 128. Asia-Pacific Pyrazinamide Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 129. Asia-Pacific Pyrazinamide Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 130. Asia-Pacific Pyrazinamide Tablets Sales Quantity by Region (2018-2023) & (K Boxes)
Table 131. Asia-Pacific Pyrazinamide Tablets Sales Quantity by Region (2024-2029) & (K Boxes)
Table 132. Asia-Pacific Pyrazinamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Pyrazinamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Pyrazinamide Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 135. South America Pyrazinamide Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 136. South America Pyrazinamide Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 137. South America Pyrazinamide Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 138. South America Pyrazinamide Tablets Sales Quantity by Country (2018-2023) & (K Boxes)
Table 139. South America Pyrazinamide Tablets Sales Quantity by Country (2024-2029) & (K Boxes)
Table 140. South America Pyrazinamide Tablets Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Pyrazinamide Tablets Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Pyrazinamide Tablets Sales Quantity by Type (2018-2023) & (K Boxes)
Table 143. Middle East & Africa Pyrazinamide Tablets Sales Quantity by Type (2024-2029) & (K Boxes)
Table 144. Middle East & Africa Pyrazinamide Tablets Sales Quantity by Application (2018-2023) & (K Boxes)
Table 145. Middle East & Africa Pyrazinamide Tablets Sales Quantity by Application (2024-2029) & (K Boxes)
Table 146. Middle East & Africa Pyrazinamide Tablets Sales Quantity by Region (2018-2023) & (K Boxes)
Table 147. Middle East & Africa Pyrazinamide Tablets Sales Quantity by Region (2024-2029) & (K Boxes)
Table 148. Middle East & Africa Pyrazinamide Tablets Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Pyrazinamide Tablets Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Pyrazinamide Tablets Raw Material
Table 151. Key Manufacturers of Pyrazinamide Tablets Raw Materials
Table 152. Pyrazinamide Tablets Typical Distributors
Table 153. Pyrazinamide Tablets Typical Customers
List of Figures
Figure 1. Pyrazinamide Tablets Picture
Figure 2. Global Pyrazinamide Tablets Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pyrazinamide Tablets Consumption Value Market Share by Type in 2022
Figure 4. 0.5g/Tablet Examples
Figure 5. 0.25g/Tablet Examples
Figure 6. Global Pyrazinamide Tablets Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Pyrazinamide Tablets Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Drugstore Examples
Figure 11. Global Pyrazinamide Tablets Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Pyrazinamide Tablets Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Pyrazinamide Tablets Sales Quantity (2018-2029) & (K Boxes)
Figure 14. Global Pyrazinamide Tablets Average Price (2018-2029) & (US$/Box)
Figure 15. Global Pyrazinamide Tablets Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Pyrazinamide Tablets Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Pyrazinamide Tablets by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Pyrazinamide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Pyrazinamide Tablets Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Pyrazinamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Pyrazinamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Pyrazinamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Pyrazinamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Pyrazinamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Pyrazinamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Pyrazinamide Tablets Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Pyrazinamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Pyrazinamide Tablets Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Pyrazinamide Tablets Average Price by Type (2018-2029) & (US$/Box)
Figure 30. Global Pyrazinamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Pyrazinamide Tablets Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Pyrazinamide Tablets Average Price by Application (2018-2029) & (US$/Box)
Figure 33. North America Pyrazinamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Pyrazinamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Pyrazinamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Pyrazinamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Pyrazinamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Pyrazinamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Pyrazinamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Pyrazinamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Pyrazinamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Pyrazinamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Pyrazinamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Pyrazinamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 53. China Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Pyrazinamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Pyrazinamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Pyrazinamide Tablets Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Pyrazinamide Tablets Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Pyrazinamide Tablets Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Pyrazinamide Tablets Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Pyrazinamide Tablets Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Pyrazinamide Tablets Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Pyrazinamide Tablets Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Pyrazinamide Tablets Market Drivers
Figure 74. Pyrazinamide Tablets Market Restraints
Figure 75. Pyrazinamide Tablets Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pyrazinamide Tablets in 2022
Figure 78. Manufacturing Process Analysis of Pyrazinamide Tablets
Figure 79. Pyrazinamide Tablets Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source